Trevi Therapeutics, Inc. (TRVI)
13.14
-0.04
(-0.30%)
USD |
NASDAQ |
Oct 07, 16:00
13.42
+0.28
(+2.13%)
After-Hours: 04:14
Trevi Therapeutics Net Income (Quarterly) : -17.80M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.80M |
| March 31, 2026 | -13.19M |
| December 31, 2025 | -8.316M |
| September 30, 2025 | -11.80M |
| June 30, 2025 | -12.30M |
| March 31, 2025 | -10.34M |
| December 31, 2024 | -11.42M |
| September 30, 2024 | -13.24M |
| June 30, 2024 | -12.35M |
| March 31, 2024 | -10.90M |
| December 31, 2023 | -7.821M |
| September 30, 2023 | -7.698M |
| June 30, 2023 | -7.145M |
| March 31, 2023 | -6.401M |
| December 31, 2022 | -5.505M |
| September 30, 2022 | -8.266M |
| June 30, 2022 | -8.052M |
| March 31, 2022 | -7.329M |
| Date | Value |
|---|---|
| December 31, 2021 | -8.521M |
| September 30, 2021 | -7.255M |
| June 30, 2021 | -9.794M |
| March 31, 2021 | -8.371M |
| December 31, 2020 | -9.523M |
| September 30, 2020 | -7.378M |
| June 30, 2020 | -7.384M |
| March 31, 2020 | -8.473M |
| December 31, 2019 | -6.537M |
| September 30, 2019 | -7.365M |
| June 30, 2019 | -7.346M |
| March 31, 2019 | -4.802M |
| December 31, 2018 | -5.982M |
| September 30, 2018 | -5.654M |
| June 30, 2018 | -4.858M |
| March 31, 2018 | -4.051M |
| December 31, 2017 | -2.378M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 17.80M |
| EPS Diluted (Quarterly) | -0.1136 |
| Enterprise Value | 1.553B |
| Earnings Yield | -2.61% |
| Normalized Earnings Yield | -2.608 |